Real-time Estimate Cboe BZX Other stock markets | 5-day change | 1st Jan Change | ||
67.20 USD | +1.86% | +6.66% | -15.01% |
03:58pm | Inflation spooks Wall Street | |
01:08pm | UnitedHealth Group, CVS Seek Recusal of FTC Commissioners from Insulin Pricing Lawsuit | MT |
May 28, 2020
Share
CVS Health will expand its COVID-19 no-cost testing program by adding 91 more test sites at select CVS Pharmacy drive-thru locations across California, including 42 in Los Angeles and Orange counties. The opening of the additional test sites adds to the 14 locations opened in California on May 22, including three Orange County locations. The company late last month committed to establish 1,000 locations across the country by the end of May, with a goal of processing up to 1.5 million tests per month, subject to availability of supplies and lab capacity, according to CVS Helath President and CEO Larry J. Merlo. Self-swab tests will be available to individuals meeting U.S. Centers for Disease Control and Prevention criteria, in addition to state and age guidelines. Patients must register in advance at CVS.com beginning Friday to schedule an appointment. Patients will be required to stay in their cars and will be directed to the pharmacy drive-thru window or a location in the parking lot at a few stores, where they will be provided with a test kit and given instructions, and a CVS Pharmacy team member will observe the self-swab process to ensure it is done properly. Tests will be sent to an independent, third-party lab for processing and the results will be available in about three days. Testing will not take place inside any retail locations, and CVS Pharmacy, HealthHUB and MinuteClinic will continue to serve customers and patients. The additional new testing sites in Los Angeles and Orange counties are located at the following CVS pharmacies: 510 S. Beach Blvd., Anaheim; 611 S. Brookhurst St., Anaheim; 188 Las Tunas Drive, Arcadia; 915 E. Arrow Highway, Azusa; 3151 Baldwin Park Blvd., Baldwin Park; 1550 Puente Ave., Baldwin Park; 1820 W. Verdugo Ave. Burbank; 21590 E. Valley Blvd., City of Industry; 901 S. Central Ave., Compton; 2701 Harbor Blvd., Costa Mesa; 8400 Firestone Blvd., Downey; 1030 Colorado Blvd., Eagle Rock; 455 N. State College Blvd., Fullerton; 155 Pacific Coast Highway, Hermosa Beach; 16961 Beach Blvd., Huntington Beach; 15520 Goldenwest St., Huntington Beach; 16922 Bolsa Chica St., Huntington Beach; 17625 Harvard Ave., Irvine; 1151 S. Harbor Blvd., La Habra; 858 N. Sunset Ave., La Puente; 6510 South Street, Lakewood; 846 W. Avenue K, Lancaster; 25829 Narbonne Ave., Lomita; 1250 E. Pacific Coast Highway, Long Beach; 3401 Katella Ave, Los Alamitos; 5176 E. Whittier Blvd., Los Angeles; 950 W. Foothill Blvd., Monrovia; 10945 Victory Blvd., North Hollywood; 3883 E. Foothill Blvd., Pasadena; 8580 Whittier Blvd., Pico Rivera; 316 S. Pacific Coast Highway, Redondo Beach; 7400 Reseda Blvd., Reseda; 602 N. El Camino Real, San Clemente; 120 E. Bonita Ave., San Dimas; --1204 San Fernando Road, San Fernando; 26861 Sierra Highway, Santa Clarita; 1954 Durfee Ave., South El Monte; 12444 Beach Blvd., Stanton; 1303 W. Sepulveda Blvd., Torrance; 15180 Kensington Park Drive, Tustin; 10048 Mills Ave., Whittier; 19701 Vanowen St., Winnetka. The Orange County sites that opened on May 22 are located at: 1150 Baker St., Costa Mesa; 921 Pacific Coast Highway, Seal Beach; and 18080 Imperial Highway, Yorba Linda.
Share
© S&P Capital IQ - 2020
Latest news about CVS Health Corporation
Inflation spooks Wall Street | 09:58am | |
UnitedHealth Group, CVS Seek Recusal of FTC Commissioners from Insulin Pricing Lawsuit | 07:08am | MT |
Barclays Upgrades CVS Health to Overweight From Equalweight, Adjusts Price Target to $82 From $63 | 05:53am | MT |
Analyst recommendations: CVS Health, Hubbell Inc, Lucid Group, Medtronic, PayPal... | 04:53am | |
Health Care Cos Up as Traders Hedge on Growth Views -- Health Care Roundup | 10-09 | DJ |
Sector Update: Health Care Stocks Rise in Late Afternoon Trading | 10-09 | MT |
Sector Update: Health Care Stocks Gain Wednesday Afternoon | 10-09 | MT |
Top Midday Stories: DOJ Mulls Breakup of Google; Boeing Pulls Latest Offer to Striking Workers | 10-09 | MT |
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias | 10-09 | DJ |
CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case | 10-09 | RE |
UnitedHealth Group, CVS Seek Recusal of FTC Commissioners from Insulin Pricing Lawsuit | 10-09 | MT |
Evercore ISI Adjusts Price Target on CVS Health to $75 From $62, Maintains Outperform Rating | 10-08 | MT |
Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer | 10-07 | CI |
Top Premarket Gainers | 10-04 | MT |
TD Cowen Upgrades CVS Health to Buy From Hold, Adjusts Price Target to $85 From $59 | 10-04 | MT |
Eli Lilly, CVS Among Companies Facing Lawsuit Over Inflated Insulin Prices | 10-03 | MT |
Humana's 2026 Results Could Take 'Significant' Hit From Potential Medicare Star Rating Cut, BofA Says | 10-03 | MT |
Eli Lilly, CVS Among Companies Facing Lawsuit Over Inflated Insulin Prices | 10-03 | MT |
Eli Lilly, CVS Pharmacy Among Companies Sued by Texas AG Over Alleged Insulin Price Increase Conspiracy | 10-03 | MT |
Eli Lilly, CVS Health Sued by Texas Attorney General Paxton Over Inflated Insulin Prices | 10-03 | MT |
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Wednesday | 10-02 | MT |
CVS Health Planning to Cut About 2,900 Jobs | 10-02 | MT |
CVS Health Considers Breaking up Insurance, Pharmacy Businesses | 10-02 | MT |
CVS Reportedly Conducts Strategic Review of Options | 10-01 | CI |
FrontView REIT raises $251 million in US IPO | 10-01 | RE |
Chart CVS Health Corporation
CVS: Dynamic Chart
Company Profile
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);- medical benefits management (25.8%);- other (0.1%).
Employees
259,500
Sector
Calendar
2024-10-20 - Détachement de
More about the company
Income Statement and Estimates
More financial data
Ratings
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
65.97USD
Average target price
69.46USD
Spread / Average Target
+5.28%
Consensus
Profit revisions
Estimate revisions
Quarterly earnings, Rate of surprise
Company calendar
- Stock Market
- Equities
- CVS Stock
- News CVS Health Corporation
- CVS Health Opening 42 Additional Drive-Thru Coronavirus Test Sites in LA/OC